Auth bypass in Sourcecodester Drug Recommendation System
CVE-2026-105704
A vulnerability was identified in SourceCodester Drug Recommendation System 1.0. This affects an unknown function of the component Auth Guard. Such manipulation of the argument user_id leads to improper authentication. The attack can be executed remotely. The exploit is publicly available and might be used.
Vulnerability class: Broken Authentication
Published · last modified .
CVSS v3 metric
CVSS v3 base score 7.3 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L.
EPSS exploit prediction
No EPSS score from FIRST.org yet. New CVEs usually get one within a few days; no score means no signal yet, not low risk. How EPSS works.
Affected products
- Sourcecodester Drug Recommendation System — versions 1.0
Weakness classification (CWE)
References
- vuldb.com/vuln/413697 (technical-description, vdb-entry)
- vuldb.com/vuln/413697/cti (signature, permissions-required)
- vuldb.com/cve/CVE-2026-105704 (third-party-advisory)
- vuldb.com/submit/992051 (third-party-advisory)
- github.com/hackliu/Vulnerability-Reports/blob/master/Drug-Recommender-Web-App/V… (exploit)
- www.sourcecodester.com/ (product)
Frequently asked questions
- What is CVE-2026-105704?
- CVE-2026-105704 is a high-severity vulnerability in Sourcecodester Drug Recommendation System, classified under Improper Authentication. CVSS score: 7.3/10. Published 2026-10-06.
- How severe is CVE-2026-105704?
- High severity. CVSS v3 base score is 7.3 out of 10.